Jennifer WARGO,Timothy P. HEFFERNAN,Swathi ARUR,Miles C. ANDREWS,Joseph MARSZALEK,Christopher VELLANO
申请号：
US16663271
公开号：
US20200164034A1
申请日:
2019.10.24
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided herein are methods for the treatment of BRAF-mutant cancer with targeted therapies including androgen receptor (AR) antagonists, G Protein-Coupled Estrogen Receptor 1 (GPER1) agonists, and/or MYC inhibitors. The therapies may be combined with BRAF and MEK-targeted therapy and/or immune checkpoint blockade.
